FDA approves new pancreatic enzyme replacement therapy

The FDA has granted approval for a new pancreatic drug, marking a shift in treatment options for patients with exocrine pancreatic insufficiency. The report also notes ongoing regulatory scrutiny regarding kratom-related substances and public health rhetoric concerning measles.